Brackmann Christoph sold 7,343 shares of NovoCure Ltd at $12.86 for −$94.4k on Nov 9, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Financial Officer
Chief Financial Officer
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$94,445.67Shares × reported price
Shares traded
7,343Ordinary Shares
Price per share
$12.86Reported price. Read footnotes for ranges.
% of reported position traded
4.02%This security and ownership context
Holdings after
175,499Direct
Trade date
Nov 9, 2026Sell
Filed
Nov 12, 2026, 4:07 PM ET3-day reporting delay
Accession
0002048634-26-000003Code S · Transaction 398758
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 182,842 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

NVCR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
NVCR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +51%1w ago +51%1d ago +13%
Returns since7d30d90d180d1y

Footnotes in full

F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2: This transaction was executed in multiple trades at prices ranging from $12.61 USD to $13.11 USD; the price reported above reflects the weighted average sale price.